Risk factors for abnormal glucose metabolism during antipsychotic treatment: A prospective cohort study
- 27 October 2023
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 168, 149-156
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development
This publication has 44 references indexed in Scilit:
- Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?BMC Psychiatry, 2011
- Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly RegistryEuropean Journal of Endocrinology, 2011
- Screening for diabetes using Japanese monitoring guidance in schizophrenia patients treated with second‐generation antipsychotics: A cross‐sectional study using baseline dataPsychiatry and Clinical Neurosciences, 2011
- How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteinsEuropean Psychiatry, 2009
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Prevalence and incidence of Type 2 diabetes and its complications 1996–2003—estimates from a Swedish population‐based studyDiabetic Medicine, 2008
- Obesity-induced Insulin Resistance and HyperglycemiaAnesthesiology, 2008
- Progression From Newly Acquired Impaired Fasting Glusose to Type 2 DiabetesDiabetes Care, 2007
- Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs ChlorpromazineNeuropsychopharmacology, 2003
- Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of SchizophreniaAmerican Journal of Psychiatry, 2002